This is the authors' abstract. We don't add key points for this paper.
The patients had good compliance with the 12-week NEXTAC program but failed to show significant improvements in disability-free survival as compared to observation alone. Further study on the progression of low muscle mass in the NEXTAC arm is needed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mitsunaga et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: